Solaris Asset Management LLC cut its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 7.0% during the second quarter, Holdings Channel reports. The institutional investor owned 1,725 shares of the company’s stock after selling 130 shares during the period. Solaris Asset Management LLC’s holdings in Nu Skin Enterprises were worth $108,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in NUS. Russell Investments Group Ltd. boosted its stake in shares of Nu Skin Enterprises by 15.0% in the first quarter. Russell Investments Group Ltd. now owns 74,166 shares of the company’s stock worth $4,122,000 after buying an additional 9,693 shares in the last quarter. ARP Americas LLC boosted its stake in shares of Nu Skin Enterprises by 42.6% in the first quarter. ARP Americas LLC now owns 6,698 shares of the company’s stock worth $372,000 after buying an additional 2,000 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in shares of Nu Skin Enterprises by 91.8% in the first quarter. Glen Harbor Capital Management LLC now owns 91,960 shares of the company’s stock worth $5,108,000 after buying an additional 44,022 shares in the last quarter. Independent Portfolio Consultants Inc. boosted its stake in shares of Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock worth $132,000 after buying an additional 40 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new stake in shares of Nu Skin Enterprises during the first quarter worth about $245,000. Institutional investors and hedge funds own 85.03% of the company’s stock.

Shares of Nu Skin Enterprises, Inc. (NUS) opened at 62.15 on Thursday. Nu Skin Enterprises, Inc. has a 12 month low of $46.35 and a 12 month high of $66.04. The stock’s 50 day moving average price is $62.93 and its 200 day moving average price is $56.34. The company has a market capitalization of $3.29 billion, a PE ratio of 20.79 and a beta of 1.31.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The firm had revenue of $550.10 million for the quarter, compared to the consensus estimate of $548.09 million. During the same quarter last year, the company earned $0.79 earnings per share. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. On average, analysts forecast that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Wednesday, August 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 48.81%.

COPYRIGHT VIOLATION WARNING: This report was originally published by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/solaris-asset-management-llc-cuts-position-in-nu-skin-enterprises-inc-nysenus/1469385.html.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Bank of America Corporation boosted their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research note on Monday, July 10th. Pivotal Research restated a “buy” rating and issued a $80.00 price objective (up from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Finally, Stifel Nicolaus set a $50.00 price objective on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $62.88.

In other news, President Ryan S. Napierski sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total value of $520,000.00. Following the transaction, the president now owns 68,170 shares of the company’s stock, valued at $4,431,050. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel D Matthew Dorny sold 8,250 shares of the firm’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $62.92, for a total value of $519,090.00. Following the completion of the transaction, the general counsel now directly owns 46,730 shares in the company, valued at approximately $2,940,251.60. The disclosure for this sale can be found here. Insiders sold 24,250 shares of company stock worth $1,490,210 in the last ninety days. Corporate insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.